Hepatic iron overload and fibrosis in patients with beta thalassemia major after hematopoietic stem cell transplantation: A pilot study

Currently, hematopoietic stem cell transplantation (HSCT) is the only curative option for patients with beta-thalassemia major, but liver iron overload in these patients will not decrease and hepatic fibrosis may still progress despite successful HSCT. Liver biopsy samples were taken from 14 patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghavamzadeh, Ardeshir, Mirzania, Mehrzad, Kamalian, Naser, Sedighi, Nahid, Azimi, Parisima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410289/
https://www.ncbi.nlm.nih.gov/pubmed/25922644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410289/
https://www.ncbi.nlm.nih.gov/pubmed/25922644

Ejemplares similares